Medline, Inc. (MDLN)
39.17
-0.30
(-0.76%)
USD |
NASDAQ |
Nov 16, 16:00
39.10
-0.07
(-0.18%)
After-Hours: 20:00
Medline Shareholders Equity (Quarterly) : 11.80B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.80B |
| June 30, 2026 | 11.57B |
| March 31, 2026 | 11.27B |
| December 31, 2025 | 10.74B |
| Date | Value |
|---|---|
| September 30, 2025 | 17.14B |
| June 30, 2025 | 16.95B |
| March 31, 2025 | |
| December 31, 2024 | 16.52B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.03B |
| AngioDynamics, Inc. | 163.96M |
| Alphatec Holdings, Inc. | 21.30M |
| AtriCure, Inc. | 533.22M |
| Baxter International, Inc. | 6.502B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.18B |
| Total Liabilities (Quarterly) | 20.79B |
| Debt to Equity Ratio | 1.072 |
| Current Ratio | 4.044 |
| Net Debt Paydown Yield | 2.62% |